FDA Inspection 1067628 — Changzhou Ruiming Pharmaceuticals Co. Ltd.
The FDA completed an inspection of Changzhou Ruiming Pharmaceuticals Co. Ltd. on Sep 13, 2018 in Changzhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Sep 13, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Changzhou (China)